NBL1
Neuroblastoma suppressor of tumorigenicity 1
Also known as: D1S1733E, DAN, DAND1, NB, NBL1_HUMAN, NO3
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P41271
- Gene
- NBL1
- Ensembl
- ENSG00000158747
- Chromosome
- 1
- Canonical length
- 181 aa
- Protein class
- Predicted intracellular proteins, Predicted secreted proteins
- Secretome location
- Secreted in other tissues
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene product is the founding member of the evolutionarily conserved CAN (Cerberus and DAN) family of proteins, which contain a domain resembling the CTCK (C-terminal cystine knot-like) motif found in a number of signaling molecules. These proteins are secreted, and act as BMP (bone morphogenetic protein) antagonists by binding to BMPs and preventing them from interacting with their receptors. They may thus play an important role during growth and development. Alternatively spliced transcript variants have been identified for this gene. Read-through transcripts between this locus and the upstream mitochondrial inner membrane organizing system 1 gene (GeneID 440574) have been observed. [provided by RefSeq, May 2013]
Canonical amino-acid sequenceUniProt
181 residues, UniProt reviewed canonical sequence.
>P41271|NBL1
1 MMLRVLVGAV LPAMLLAAPP PINKLALFPD KSAWCEAKNI TQIVGHSGCE AKSIQNRACL
61 GQCFSYSVPN TFPQSTESLV HCDSCMPAQS MWEIVTLECP GHEEVPRVDK LVEKILHCSC
121 QACGKEPSHE GLSVYVQGED GPGSQPGTHP HPHPHPHPGG QTPEPEDPPG APHTEEEGAE
181 DLocalizationUniProt · AlphaFold · HPA
Whether an antibody against NBL1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.53
- Highest tissue expression
- 590 nTPM
Expression across tissuesHPA
Tissue
- ovary: 590 nTPM
- cervix: 515 nTPM
- prostate: 362 nTPM
- vagina: 356 nTPM
- small intestine: 297 nTPM
- lung: 295 nTPM
Single-cell type
- ovarian stromal cells: 497 nCPM
- enterocytes: 413 nCPM
- peritubular myoid cells: 363 nCPM
- colonocytes: 341 nCPM
- leydig cells: 306 nCPM
- esophageal basal cells: 255 nCPM
Immune cell
- memory CD4 T-cell: 0.8 nTPM
- naive CD4 T-cell: 0.6 nTPM
- MAIT T-cell: 0.4 nTPM
- memory CD8 T-cell: 0.4 nTPM
- naive CD8 T-cell: 0.4 nTPM
- gdT-cell: 0.1 nTPM
Brain region
- hippocampal formation: 200 nTPM
- midbrain: 191 nTPM
- choroid plexus: 156 nTPM
- cerebral cortex: 156 nTPM
- hypothalamus: 138 nTPM
- pons: 137 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.02
- gnomAD pLI
- 0.06
- gnomAD missense Z
- 1.52
- DepMap mean gene effect
- -0.08
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- determination of dorsal identity
- negative regulation of BMP signaling pathway
- negative regulation of monocyte chemotaxis
- nervous system development
- neuron projection morphogenesis
- positive regulation of neuron differentiation
- sequestering of BMP from receptor via BMP binding
- sequestering of BMP in extracellular matrix
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- DAN
- Cystine knot, C-terminal
- Cystine-knot cytokine
- DAN domain
- Neuroblastoma suppressor of tumourigenicity 1
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of NBL1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NBL1 as an antibody target. Whether an autoantibody or antibody against NBL1 could matter depends on whether native NBL1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NBL1 is annotated as secreted, so native NBL1 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label NBL1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...